Financial Results : SPIMACO H1 2025 profit rises to SAR 103M, Q2 at SAR 33M

SPIMACO H1 2025 profit rises to SAR 103M, Q2 at SAR 33M

03/08/2025 Argaam Exclusive

View other reports

Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) posted a net profit rise to SAR 103 million in H1 2025, compared to SAR 52.4 million in the prior-year period.

Before minority interest, net profit stood at SAR 111.1 million for the first half of 2025, from SAR 57.6 million in the year-earlier period.


Financials (M)

Item 6m 2024 6m 2025 Change‬
Revenues 849.45 885.60 4.3 %
Gross Income 427.27 422.97 (1.0 %)
Operating Income 96.05 120.43 25.4 %
Net Income 52.45 103.45 97.3 %
Average Shares 120.00 120.00 -
Earnings Per Share before unusual items (Riyals) 0.41 0.70 67.5 %
EPS (Riyal) 0.44 0.86 97.3 %

The company cited a 4.3% year-on-year (YoY) increase in revenues to SAR 885.6 million for the six-month period, primarily due to higher government sales, growth in the private sector, and increased contractual manufacturing activities.

 

Selling, marketing, general, and administrative expenses decreased by 4.7% YoY to SAR 264.9 million. Meanwhile, SPIMACO’s operating income rose to SAR 145.9 million on generating profits from the sale of fixed assets.

 

In Q2 2025, net earnings grew to SAR 33 million, from SAR 17.1 million in the year-earlier period as revenues climbed by 7.3% YoY to SAR 400.8 million. Operating income also skyrocketed by 96.8% YoY to SAR 30.2 million.

 

Compared to Q1 2025, net earnings more than halved from SAR 70.8 million, hurt by a 17.3% fall quarter-on-quarter (QoQ) in topline due to lower sales to the private sector.

 

Gross profits also dropped 15.2% QoQ, with research and development (R&D) expenses rising by SAR 2.2 million.



Current Quarter Comparison (M)

Compared With The
Item Q2 2024 Q2 2025 Change‬
Revenues 373.50 400.76 7.3 %
Gross Income 176.13 194.08 10.2 %
Operating Income 22.49 57.73 156.8 %
Net Income 17.10 32.63 90.8 %
Average Shares 120.00 120.00 -
Earnings Per Share before unusual items (Riyal) 0.12 0.27 125.8 %
EPS (Riyal) 0.14 0.27 90.8 %

Total shareholders’ equity, after minority interest, reached SAR 1.50 billion as of June 30, 2025, up from SAR 1.41 billion a year earlier.

 

Accumulated losses came in at SAR 16.8 million by the end of the six-month period, accounting for 1.4% of the company's capital.

Attached document:

 

 

View More Financial Results

 

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Contact Us (+966)-92000-7759

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.